SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-077144
Filing Date
2024-09-10
Accepted
2024-09-10 09:15:59
Documents
14
Period of Report
2024-09-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0214018-8ka1_allarity.htm   iXBRL 8-K/A 61727
2 CERTIFICATE OF CORRECTION TO THE SEVENTH CERTIFICATE OF AMENDMENT TO THE CERTIFI ea021401801ex3-3_allarity.htm EX-3.3 13965
  Complete submission text file 0001213900-24-077144.txt   264953

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE allr-20240903.xsd EX-101.SCH 3015
4 XBRL LABEL FILE allr-20240903_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE allr-20240903_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0214018-8ka1_allarity_htm.xml XML 5342
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41160 | Film No.: 241288874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)